9th Tumor Models San Francisco Summit 2025, January 29-30, 2025

Conference

genOway presentation

Event
-
January 22, 2025

genOway's presentation on Wednesday, January 29, 2025 | 4 p.m. PST:

Assessment of translational tumor biology and efficacy in humanized mouse models

  • Outlining BRGSF-HIS mice: a CD34+-reconstituted model with functional human lymphoid and myeloid compartments without side effects
  • Investigating human immune cell recruitment into tumor microenvironment in BRGSF-HIS mice
  • Assessment of anti-tumoral compounds in BRGSF-HIS mice
  • Use of hFcγR model to investigate the Fc-mediate effector functions of therapeutic antibodies

9th Tumor Models San Francisco Summit 2025, January 29-30, 2025

Get in touch

Let us know how we can help

Other news & events

AACR Annual Meeting 2026, San Diego, CAL, April 17-22
Conference
genOway presentation
Event
-
Mar 2026
Read on
Lunch & Learn: Accelerating Drug Development Through Predictive and Translatable In Vivo Models
genOway presentation
Event
-
Mar 2026
Read on
Revolutionizing the Prediction of Antibody Therapies in Humans with a Unique Mouse Model
Partnership
News
-
Feb 2026
Read on
NextGen Biomed 2026, London, UK, March 24-25
Conference
Event
-
Feb 2026
Read on
10th Tumor Models Summit San Francisco, January 28-29, 2026
Conference
genOway presentation
Event
-
Jan 2026
Read on
Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe